Back

Beyond hypocapnia: standardised capillary oxygen partial pressure predicts risk and treatment response in PAH

31 August 2026 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Pulmonary hypertension and right ventricular Pulmonary Hypertension ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Tilmann Thomas Kramer

Cologne (Germany)

5 More presentations in this session

Presentation thumbnail
Characterization of coronary microvascular dysfunction in patients with pulmonary hypertension
Doctor O. Velollari (Mainz, DE)
Abstract
Presentation thumbnail
Effects of high-intensity inspiratory muscle training on inspiratory muscle strength and exercise capacity in pulmonary arterial hypertension
Ms P. Wu (Taipei, TW)
Abstract
Presentation thumbnail
A CT echo triage model predicts markedly elevated pulmonary vascular resistance and right ventricular failure phenotype at catheterization
Doctor M. Al-Sarmi (Dublin, IE)
Abstract
Presentation thumbnail
Diabetes is associated with reduced survival in controls but not in patients with idiopathic pulmonary arterial hypertension
Associate Professor B. Kjellstrom (Lund, SE)
Abstract
Presentation thumbnail
Phase 1 safety, tolerability, and pharmacokinetics of NS-863 supporting development for pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease
Professor Y. Tamura (Tokyo, JP)
Abstract

Access the full session

Session thumbnail
Pulmonary hypertension and right ventricular

The Event

Event poster

ESC Congress 2026

31 August 2026 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Clinical, laboratory associates and prognostic significance of hypocapnia in acute heart failure. 
23 May 2022
thumbnail
Congress Presentation
Long-term follow-up of hemodynamic changes between balloon pulmonary angioplasty with and without medical therapy
29 August 2025
thumbnail
Congress Presentation
Metabolic reprogramming in pulmonary arterial hypertension: is it a cancer-like disease?
27 August 2021
thumbnail
Congress Presentation
Are the PAH risk stratification tools useful in post-capillary pulmonary hypertension? Insights from the PH-HF study
23 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources